[Experience with Tanderil in inflammatory diseases of the adnexa uteri and other gynecologic indications].
D000328:Adult; D004841:Episiotomy / Q000009:adverse effects; D005260:Female; D005499:Folliculitis / Q000188:drug therapy; D005667:Furunculosis / Q000188:drug therapy; D005831:Genital Diseases, Female / Q000188:drug therapy*; D006801:Humans; D008413:Mastitis / Q000188:drug therapy; D008875:Middle Aged; D010113:Oxyphenbutazone / Q000627:therapeutic use*; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy*; D049590:Postpartum Period; D011247:Pregnancy; D013924:Thrombophlebitis / Q000188:drug therapy; D014594:Uterine Neoplasms / Q000188:drug therapy
D010113:Oxyphenbutazone
Erfahrungen mit Tanderil bei entzündlichen Erkrankungen der Adnexe und anderen gynäkologischen Indikationen.